“What’s in a ‘code’?” – to paraphrase a famous line of an even more famous writer (“What’s in a name?” line from the play Romeo & Juliet by W. Shakespeare). It is known that for the purpose of the Falsified Medicines Directive (FMD) implementation, the 2D Data Matrix code has been chosen for the encoding […]
OSMR announces a change in its Management Board componence: starting with 01.10.2022, Mr. Virgil Dinulescu will no longer act as representative for The Association of Pharmaceuticals Distributors and Retailers in Romania (ADRFR) within the OSMR Board. During his tenure as Board Member, Mr. Dinulescu has been a key element in the success of the serialisation […]
Please be informed that during the time interval 24.10 – 25.10.2022, between: 19:00 – 01.:00, a maintenance session is scheduled on the Production (PROD) Environment of the National Medicines Verification System (NMVS) with the purpose of implementing the new version of NMVS – Core 1.11. Within the specified interval, the NMVS will experience sporadic downtimes.
EMVO announced the launch of the Self-Service Portal – a new platform designed to assist in finding all the information needed. Please click on the link below for the details: EMVO LoA
Please click on the link below to view the third edition of the OSMR Newsletter of this year. NL – August
EMVO and the NMVOs have prepared a special summer edition of the EMVS newsletter. Please click on the link below for its content. EMVS Community Newsletter – August 2022
OSMR is pleased to announce that the Alert Manager Application – used within OSMR to manage the alerts raised by the National Medicines Verification System (NMVS) has been connected to the EU AMS Hub. This is an important step of the Pilot phase of the Alert Management System (AMS) project that has started on October […]
Please be informed that during the time interval 10.08.2022 – 11.08.2022, between: 23:00 – 05:00, a maintenance session is scheduled on the Production (PROD) Environment of the National Medicines Verification System (NMVS). Within the specified time interval the NMVS – Reporting Tool will be unavailable for a short period of time.
How easy is it to spot a falsified medicine? This is nearly impossible just by looking at the medicine itself or at its packaging. The patient is facing dangers ranging from lack of effect of the respective medicine, more precisely therapeutic ineffectiveness due to ingredients – active substances and excipients – of inadequate quality, or […]
The latest Letter of Announcement from EMVO shares information about the status of the packs intended for the Greek and Italian market. Please click on the link below for the details. EMVO LoA